Laura Sepp-Lorenzino - Insider Trading & Ownership

Location
C/O Intellia Therapeutics, Inc., 40 Erie Street, Suite 130, Cambridge, MA
Summary
The estimated net worth of Laura Sepp-Lorenzino is at least $1.26M dollars as of June 4, 2025. Laura Sepp-Lorenzino is the EVP, Chief Scientific Officer of Intellia Therapeutics, Inc. and owns shares of Intellia Therapeutics, Inc. (NTLA) stock worth about $943K. Laura Sepp-Lorenzino is the Director of Taysha Gene Therapies, Inc. and owns shares of Taysha Gene Therapies, Inc. (TSHA) stock worth about $318K.
Signature
/s/ Kamran Alam, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Laura Sepp-Lorenzino

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NTLA Intellia Therapeutics, Inc. EVP, Chief Scientific Officer $943K -$109K -10.4% Jan 3, 2025
TSHA Taysha Gene Therapies, Inc. Director $318K Jun 2, 2025

Insider Transactions Reported by Laura Sepp-Lorenzino:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.